Survival Advantage of Trans-Arterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy

PURPOSE: To measure TACE utilization and survival benefit among patients with HCC in the SEER patient population. METHOD AND METHODS: A retrospective study identified 37, 832 patients with HCC diagnosed between 1991 and 2011. Survival was estimated by Kaplan-Meier method and compared using the log r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vasc Interv Radiol
Main Authors: Gray, SH, White, JA, Li, Peng, Kilgore, M, Redden, DT, Abdel Aal, AK, Simpson, H, McGuire, B, Eckhoff, DE, Dubay, DA
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5258671/
https://ncbi.nlm.nih.gov/pubmed/27939085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2016.09.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados